On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Deutsches Krebsforschungszentrum Heidelberg's own share of each project, not the project's full budget.
- Horizon Europe€59.5M · 79 projects
- Horizon 2020€49.1M · 65 projects
- FP7 (2007 to 2013)€32.9M · 66 projects
- EU4Health Programme (EU4H)€1.4M · 9 projects
- Digital Europe Programme (DIGITAL)€1.1M · 2 projects
- Euratom Research and Training Programme (EURATOM)€69k · 1 project
- 3rd Health Programme€17k · 1 project
- Erasmus+ (ERASMUS+)€0 · 1 project
Projects
224 EU-funded projects, newest first. Deutsches Krebsforschungszentrum Heidelberg led 86 of them as coordinator. Each links to the official record.
- IMMSTRESSCoordinator
Targeting stress signaling pathways to enhance prostate cancer immunotherapy
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€202ktheir share - PACTPartner
Parasite Adaptive skills and how to Counter Them
Horizon Europe · 2027–2031 · Project on CORDIS ↗
€290ktheir share - ION-CANDELCoordinator
Ion channelome of solid tumours: Novel immunotherapy targets for cancer-specific mRNA and drug delivery
Horizon Europe · 2027–2029 · Project on CORDIS ↗
€218ktheir share - TagTICPartner
Target mining for the development of therapeutics against pathogen-induced cancers
Horizon Europe · 2027–2031 · Project on CORDIS ↗
€387ktheir share - FutureMINDPartner
Training Europe’s Future Leaders in AI-driven Neuro-Oncology Diagnostics and Discovery
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€290ktheir share - SafeCureCoordinator
Safeguard Repressor-Mediated Cell Fate Lock Gene Therapy for Glioblastoma
Horizon Europe · 2027–2028 · Project on CORDIS ↗
€150ktheir share - LIVEMAPCoordinator
LIVEMAP: Live-cell mapping of drug–protein interactions across the human proteome
Horizon Europe · 2027–2028 · Project on CORDIS ↗
€150ktheir share - NAVIGATEAssociated partner
Next-generation AI and Computational Biology for Translational Excellence
Horizon Europe · 2026–2032 · Project on CORDIS ↗
- InnovaRTBRAINPartner
Innovative Radiation Therapy for brain tumors
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€290ktheir share - PROMETHEUSCoordinator
PROstate cancer Multimodal Explainable Transferable Holistic Expert for Universal Stratification
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€1.6Mtheir share - PREFERENCEPartner
Exploring Extended Field-of-view PET for precision medicine
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€290ktheir share - REGENER-OMIXCoordinator
Fibroblasts-microbiome crosstalk in tissue regeneration and fibrosis: unraveling novel therapeutic targets through single nucleus RNA-seq, multi-omics and spatial analysis
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€401ktheir share - AdenoRegulateCoordinator
Uncovering how environmental cues regulate metabolism via the anti-growth hormone Adenosine
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€2.5Mtheir share - EUcanAIPartner
European Unified Cancer diagnostics and treatment AI agent
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€492ktheir share - PRAISE-U PlusPartner
PRostate cancer Awareness and Initiative for Screening in the European Union Plus
EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗
€300ktheir share - SPHEROMOUSECoordinator
Validating a versatile platform of novel standardized and biobankable preclinical mouse tumor models
Horizon Europe · 2026–2027 · Project on CORDIS ↗
€150ktheir share - PRECISION ImmunoRadPartner
Personalized molecular reprogramming of the tumor immune microenvironment and engineered adoptive cell transfer in synergy with ion-beam radiotherapy for next-generation curative cancer treatments
Horizon Europe · 2026–2032 · Project on CORDIS ↗
€1.2Mtheir share - AI-TreatCancerCoordinator
AI-guided personalized T cell receptor transgenic T cell therapy against cancer
Horizon Europe · 2026–2027 · Project on CORDIS ↗
€150ktheir share - IGNIDTEAssociated partner
Image-guided Diagnostics and Therapy - Novelty, Internationality and Excellence
Horizon Europe · 2026–2031 · Project on CORDIS ↗
- REVIVECoordinator
Reversing Tumor Immunotherapy Resistance via TME Modulation
Horizon Europe · 2026–2027 · Project on CORDIS ↗
€150ktheir share - TI-uORFeCoordinator
Exploiting Therapy-Induced Neo-Epitopes to Overcome Drug Resistance in Triple-Negative Breast Cancer
Horizon Europe · 2025–2027 · Project on CORDIS ↗
€150ktheir share - HyBOTCoordinator
Parasite-inspired Soft-rigid Hybrid Microrobots for Brain Tissue Penetration
Horizon Europe · 2025–2027 · Project on CORDIS ↗
€218ktheir share - UNCAN-ConnectPartner
UNCAN-CONNECT: Decentralized Collaborative Network for Advancing Cancer Research and Innovation
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€983ktheir share - CancerWatch JAAssociated partner
Improving Quality and Timeliness of Cancer Registry Data feeding into the European Cancer Information System
EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗
€39ktheir share - AI-NextPartner
A Foundation Model for Next-Generation Generalizable AI in Neuro-Radiology
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€265ktheir share - €983ktheir share
- Unstable GenomeCoordinator
The Tipping Point from Genome Instability to Cancer
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€2.0Mtheir share - FusionTRACECoordinator
Deciphering context-dependent roles of oncogenic gene fusions in vivo
Horizon Europe · 2025–2030 · Project on CORDIS ↗
€2.0Mtheir share - IFIGENEIAPartner
Innovative Facility for Isotope GENeration with Efficient Ion Accelerator
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€487ktheir share - EASIGEN-DSAssociated partner
DESIGN STUDY FOR A EUROPEAN INFRASTRUCTURE ON ADVANCED GENOMICS TECHNOLOGIES
Horizon Europe · 2025–2028 · Project on CORDIS ↗
- VIDAAssociated partner
VHIO International postDoctoral programme for translAtional research
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- BoneOscopyCoordinator
Live Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone Cancer
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€816ktheir share - GRASSHOPPERPartner
The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€110ktheir share - MiCCrobioTAcklePartner
Advancing Research at the Intersection Between Gut Microbiota and Cancer Cachexia to Train Europe’s Future Leaders in Microbiota Medicine
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€261ktheir share - PoQusPartner
Portable Quantum Sensors for Neurosurgery
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€1.2Mtheir share - JANE-2Associated partner
Joint Action on Networks of Expertise on Cancer
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€452ktheir share - CENTRIC-BRAINCoordinator
Characterizing and harnessing tumor-reactive T cells in the brain
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€2.0Mtheir share - METABACCoordinator
Functional characterization of the colorectal cancer metastasis microbiome
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€1.5Mtheir share - UPLIFTPartner
UPright radiotherapy: Learning, Innovation, Fellowship and Training
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€261ktheir share - EUnetCCC JAAssociated partner
The European Comprehensive Cancer Centre Network
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€74ktheir share
Show 40 more projects
- CarrerasPathfindersAssociated partner
Enabling the next generation in search of blood cancer cures
Horizon Europe · 2024–2029 · Project on CORDIS ↗
- VulnerableInhibitionCoordinator
Cognitive deficits resulting from selective vulnerability of septal inhibitory neurons: mitochondrial dysfunction as a driver?
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€2.0Mtheir share - MENTORINGPartner
Addressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients.
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€474ktheir share - TimedEnhancerCoordinator
Temporal dependence of enhancer function
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€1.5Mtheir share - EUCanScreenAssociated partner
Implementation of cancer screening programmes.
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€97ktheir share - RESOLVEPartner
Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€135ktheir share - 4D-therapyCoordinator
Multimodal “4D”-therapy of pediatric high grade glioma
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€1.5Mtheir share - Cancer-HarakiriCoordinator
Targeting the undruggable: Leveraging neomorphic DNA-binding preferences of chimeric fusion oncogenes to promote cancer suicide
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€2.0Mtheir share - ARTEMISPartner
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€921ktheir share - THRIVEPartner
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€350ktheir share - BEHIND-MSCoordinator
The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€3.7Mtheir share - CAPTIVATEPartner
CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€676ktheir share - NUTRIOMEPartner
Precision nutrition and postprandial immune responses
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€261ktheir share - MRDAMLCoordinator
Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myeloid leukemia
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€174ktheir share - AECC TalentAssociated partner
FCAECC Fellowship programme for talented researchers in cancer
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- SpatialTMEMetabolismCoordinator
Spatial Quantification of Cellular Metabolism in the Tumor Immune Microenvironment
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€1.5Mtheir share - PEPSCoordinator
PErPetuating Stemness: From single-cell analysis to mechanistic spatio-temporal models of neural stem cell dynamics
Horizon Europe · 2023–2029 · Project on CORDIS ↗
€4.0Mtheir share - PIECESPartner
TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€154ktheir share - TAIPOCoordinator
Trustworthy AI tools for personalized oncology
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€2.0Mtheir share - CCI4EUPartner
COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€174ktheir share - SOLACEPartner
Strengthening the screening of Lung Cancer in Europe
EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗
€224ktheir share - CASSISCoordinator
A single-cell atlas of human soft tissue sarcoma ecosystems with focus on mechanisms of immune evasion
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€190ktheir share - VIBEBOTCoordinator
Vibrational Micro-robots in Viscoelastic Biological Tissues
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€879ktheir share - CancAHRCoordinator
Understanding the complex biology of AHR activation in cancer
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€2.0Mtheir share - DRILLCoordinator
Decoding Requirements for Infiltration of T ceLLs into solid tumors
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€1.5Mtheir share - CarrerasLeadersAssociated partner
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- Maxima ButterflyAssociated partner
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- NEARDATAPartner
Extreme Near-Data Processing Platform
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€385ktheir share - CloudSkinPartner
Adaptive virtualization for AI-enabled Cloud-edge Continuum
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€367ktheir share - EUonQoLPartner
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€246ktheir share - LUCIAPartner
Understanding Lung Cancer related risk factors and their Impact
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€584ktheir share - EUCAIMPartner
European Federation for Cancer Images
Digital Europe Programme (DIGITAL) · 2023–2026 · Project on the EU portal ↗
€543ktheir share - MELCAYAPartner
Novel health care strategies for melanoma in children, adolescents and young adults
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€432ktheir share - PREFERABLE-IIPartner
PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€414ktheir share - ACHILLEUSCoordinator
Next-Generation Drug Discovery Platform for Targeting Cancer Stem Cell Pathways
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€2.4Mtheir share - I4WORLDAssociated partner
Imaging and Characterization for a Sustainable World
Horizon Europe · 2022–2027 · Project on CORDIS ↗
- GDIPartner
Genomic Data Infrastructure
Digital Europe Programme (DIGITAL) · 2022–2027 · Project on the EU portal ↗
€547ktheir share - BUMPERPartner
Boosting the Usability of the european union Mobile aPp for cancEr pRevention
EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗
€104ktheir share - 1COREAssociated partner
One Comprehensive Research-Intensive European University
Erasmus+ (ERASMUS+) · 2022–2026 · Project on the EU portal ↗
- engineereD to ClearCoordinator
Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia
Horizon Europe · 2022–2024 · Project on CORDIS ↗
€190ktheir share
Showing the 80 most recent of 224 projects.
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karolinska InstitutetSweden · 27 shared projects
- European Molecular Biology LaboratoryGermany · 24 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 23 shared projects
- Ruprecht-Karls-Universitaet HeidelbergGermany · 23 shared projects
- Universitatsklinikum HeidelbergGermany · 22 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 20 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 20 shared projects
- Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ZiekenhuisNetherlands · 20 shared projects
- Fondazione Irccs Istituto Nazionale Dei TumoriItaly · 19 shared projects
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 17 shared projects
- Academisch Ziekenhuis GroningenNetherlands · 17 shared projects
- Fundacio Centre de Regulacio GenomicaSpain · 17 shared projects
- Institut CurieFrance · 17 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 16 shared projects
- Tartu UlikoolEstonia · 15 shared projects
- Medizinische Universitaet WienAustria · 15 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- DNA viruses
- HIV
- RNA
- adverse drug reactions
- alcohols
- alkaline earth metals
- allergology
- alzheimer
- amines
- amorphous semiconductors
- artificial intelligence
- autoimmune diseases
- automation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
